Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick D Mitchell

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Chest|November 8, 2016
Epithelial-Derived Cytokines in AsthmaPatrick D Mitchell, Paul M O'Byrne
Advances in Therapy|May 23, 2014
Bronchoscopic management of malignant airway obstructionPatrick D Mitchell, Marcus P Kennedy
Chest|May 10, 2016
Surfactant Protein-D and AsthmaPatrick D Mitchell, Paul M O'Byrne
Pharmacology & Therapeutics|July 2, 2016
Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthmaPatrick D Mitchell, Paul M O'Byrne
Seminars in Respiratory and Critical Care Medicine|October 23, 2025
Diffuse Alveolar HemorrhageJohn Murray, Shane O'Brien, Patrick D Mitchell
European Journal of Clinical Pharmacology|August 28, 2012
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteersRenli Teng, Patrick D Mitchell, Kathleen A Butler
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2011
Hypoxemia in patients with COPD: cause, effects, and disease progressionBrian D Kent, Patrick D Mitchell, Walter T McNicholas
Respiratory Care|January 22, 2015
Subcutaneous Emphysema in Acute Asthma: A Cause for Concern?Patrick D Mitchell, Thomas J King, Donal B O'Shea
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteersPaul D Martin, Patrick D Mitchell, Dennis W Schneck
Handbook of Experimental Pharmacology|November 20, 2016
Anti-IgE and Biologic Approaches for the Treatment of AsthmaPatrick D Mitchell, Amani I El-Gammal, Paul M O'Byrne
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Chest|November 8, 2016
Epithelial-Derived Cytokines in AsthmaPatrick D Mitchell, Paul M O'Byrne
Advances in Therapy|May 23, 2014
Bronchoscopic management of malignant airway obstructionPatrick D Mitchell, Marcus P Kennedy
Chest|May 10, 2016
Surfactant Protein-D and AsthmaPatrick D Mitchell, Paul M O'Byrne
Pharmacology & Therapeutics|July 2, 2016
Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthmaPatrick D Mitchell, Paul M O'Byrne
Seminars in Respiratory and Critical Care Medicine|October 23, 2025
Diffuse Alveolar HemorrhageJohn Murray, Shane O'Brien, Patrick D Mitchell
European Journal of Clinical Pharmacology|August 28, 2012
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteersRenli Teng, Patrick D Mitchell, Kathleen A Butler
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2011
Hypoxemia in patients with COPD: cause, effects, and disease progressionBrian D Kent, Patrick D Mitchell, Walter T McNicholas
Respiratory Care|January 22, 2015
Subcutaneous Emphysema in Acute Asthma: A Cause for Concern?Patrick D Mitchell, Thomas J King, Donal B O'Shea
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteersPaul D Martin, Patrick D Mitchell, Dennis W Schneck
Handbook of Experimental Pharmacology|November 20, 2016
Anti-IgE and Biologic Approaches for the Treatment of AsthmaPatrick D Mitchell, Amani I El-Gammal, Paul M O'Byrne
Pageof 4